Company / SG&A per Share
Royalty Pharma plc SG&A per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.95
FY2025
5-year range
$0.28 / $0.95
FY2021-FY2025
Trend
+76.0%
vs FY2024
Sector context
#126 of 210
Health Care
What the data says
At $0.95, Royalty Pharma plc's sg&a per share ranks #85 of 210 in the Health Care sector. Increased from $0.60 to $0.95 over the past 2 years.
Based on SEC 10-K filings.
0.95 in FY2025 with a 5-year CAGR of +42.0%.
Increased from $0.60 to $0.95 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +25.3%
- 5-Year CAGR
- +42.0%
- 10-Year CAGR
- -
Sector benchmark
#85 of 210 in Health CareTop 40% of 210This company $0.95 Sector average $29.50
▼
-96.8% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share increased 76.0% year-over-year.
- Ranks #126 out of 210 companies in the Health Care sector.
- Lowest sg&a per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.91 (distress zone, below 1.8 threshold)
- Strong profit margin: 38.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.95 | +76.0% |
| FY2024 | $0.54 | -10.2% |
| FY2023 | $0.60 | +24.4% |
| FY2022 | $0.48 | +75.7% |
| FY2021 | $0.28 | +67.1% |
| FY2020 | $0.16 | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026